Home > Healthcare > Drug Device Combination > Drug Filled Devices > Contraceptives Market

Contraceptives Market Trends

Report ID: GMI430
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Contraceptives Market Trends

The increasing demand for long-acting reversible contraceptives (LARCs), such as IUDs and contraceptive implants, has emerged as a prominent trend due to their high efficacy and long-term protection. LARCs are gaining popularity because they require minimal maintenance and are preferred by women seeking longer-term solutions for birth control.

Additionally, the rising popularity of over-the-counter contraceptives, such as condoms and emergency contraceptive pills, is boosting market growth, driven by ease of access and affordability. The rise of digital health platforms offering online consultations and prescription services for contraceptives is also reshaping the distribution landscape, providing users with convenient, remote access to birth control.
Another significant trend influencing the market is the increasing focus on male contraceptives. Research and development in male contraceptive options, including hormonal and non-hormonal methods, are progressing, with several products currently in clinical trials. This diversification in contraceptive options is likely to create new opportunities in the market. Additionally, growing awareness of environmental sustainability has led to a rise in demand for eco-friendly and biodegradable contraceptive products, further shaping market preferences.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global contraceptives industry was valued at USD 23 billion in 2023 and is expected to exhibit a CAGR of 6.3% from 2024 to 2032, attributed to increasing emphasis on prevention of sexually transmitted diseases, and growing awareness about new technologies for pregnancy prevention.

The devices segment generated the highest revenue of USD 16 billion in 2023 as their reliability and ease of use make them appealing to women seeking consistent and low-maintenance birth control.

North America contraceptives market accounted for USD 7.5 billion in 2023 and is anticipated to record a CAGR of 4% between 2024 to 2032, due to rising awareness of family planning and reproductive health, supported by government initiatives and healthcare policies.

Bayer AG, Church & Dwight Co., Inc., Cooper Companies, Evofem Biosciences, HRA Pharma, Maxwellia Ltd, Mayer Laboratories, Inc., and Mithra Pharmaceuticals among others.